ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v20i1.2534ppharm-2260Research ArticleКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИCLINICAL RECOMMENDATIONSСовременные подходы к ведению детей с внебольничной пневмониейModern approaches at the management of children with community-acquired pneumoniahttps://orcid.org/0000-0003-3987-8112БарановА. А.BaranovAleksander A.

Москва

Moscow

https://orcid.org/0000-0001-8728-1113КозловР. С.KozlovRoman S.

Саратов

Saratov

https://orcid.org/0000-0002-2209-7531Намазова-БарановаЛ. С.Namazova-BaranovaLeyla S.

Намазова-Баранова Лейла Сеймуровна, 

руководитель НИИ педиатрии и охраны здоровья детей НКЦ №2 ФГБНУ «РНЦХ им. акад. Б.В. Петровского»;

доктор медицинских наук, профессор, академик РАН, заведующая кафедрой факультетской педиатрии педиатрического факультета;

президент Союза педиатров России, 

119333, Москва, ул. Фотиевой, д. 10

Moscow

lsnamazova@yandex.ruhttps://orcid.org/0000-0001-7916-1488АндрееваИ. В.AndreevaIrina V.

Саратов

Saratov

https://orcid.org/0000-0001-6474-6766БакрадзеМ. Д.BakradzeMaiya D.https://orcid.org/0000-0001-7398-0562ВишнёваЕ. А.VishnevaElena A.

Москва

Moscow

КарасеваМ. С.KarasevaMariya S.

Москва

Moscow

КузнецоваТ. А.KuznetsovaTatiana A.https://orcid.org/0000-0002-7447-0625КуличенкоТ. В.KulichenkoTatiana V.

Москва

Moscow

ЛашковаЮ. С.LashkovaYulia S.

Москва

Moscow

ЛютинаЕ. И.LyutinaElena I.МанеровФ. К.ManerovFarok K.https://orcid.org/0000-0001-8077-5313МаянскийН. А.MayanskiyNikolay A.

Москва

Moscow

ПлатоноваМ. М.PlatonovaMariya M.

Москва

Moscow

https://orcid.org/0000-0003-4655-3375ПоляковаА. С.PolyakovaAnastasiya S.

Москва

Moscow

https://orcid.org/0000-0002-3678-7939СелимзяноваЛ. Р.SelimzyanovaLilia R.

Москва

Moscow

https://orcid.org/0000-0001-8085-4513ТаточенкоВ. К.TatochenkoVladimir K.СтаровойтоваЕ. В.StarovoytovaElena V.https://orcid.org/0000-0002-7316-9187СтецюкО. У.StetsioukOlga U.

Саратов

Saratov

https://orcid.org/0000-0003-0797-5612ФедосеенкоМ. В.FedoseenkoMarina V.

Москва

Moscow

ЧащинаИ. Л.ChashchinaIrina L.

Москва

Moscow

ХарькинА. В.KharkinAndrey V.Первый МГМУ им. И.М. Сеченова (Сеченовский Университет); НИИ педиатрии и охраны здоровья детей НКЦ №2 ФГБНУ «РНЦХ им. акад. Б.В. Петровского»РоссияSechenov First Moscow State Medical University; Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of SurgeryRussian FederationСаратовский ГМУ им. В.И. РазумовскогоРоссияV.I. Razumovsky Saratov State Medical UniversityRussian FederationНИИ педиатрии и охраны здоровья детей НКЦ №2 ФГБНУ «РНЦХ им. акад. Б.В. Петровского»; РНИМУ им. Н.И. ПироговаРоссияResearch Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery; Pirogov Russian National Research Medical UniversityRussian FederationСоюз педиатров РоссииРоссияThe Union of Pediatricians of RussiaRussian FederationНИИ педиатрии и охраны здоровья детей НКЦ №2 ФГБНУ «РНЦХ им. акад. Б.В. Петровского»РоссияResearch Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of SurgeryRussian FederationРНИМУ им. Н.И. ПироговаРоссияPirogov Russian National Research Medical UniversityRussian FederationРНИМУ им. Н.И. Пирогова; НМИЦ здоровья детейРоссияPirogov Russian National Research Medical University; National Medical Research Center of Children’s HealthRussian FederationПервый МГМУ им. И.М. Сеченова (Сеченовский Университет); НИИ педиатрии и охраны здоровья детей НКЦ №2 ФГБНУ «РНЦХ им. акад. Б.В. Петровского»; РНИМУ им. Н.И. ПироговаРоссияSechenov First Moscow State Medical University; Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery; Pirogov Russian National Research Medical UniversityRussian FederationНМИЦ здоровья детейРоссияNational Medical Research Center of Children’s HealthRussian Federation2023270220232011741Copyright © Баранов А.А., Козлов Р.С., Намазова-Баранова Л.С., Андреева И.В., Бакрадзе М.Д., Вишнёва Е.А., Карасева М.С., Кузнецова Т.А., Куличенко Т.В., Лашкова Ю.С., Лютина Е.И., Манеров Ф.К., Маянский Н.А., Платонова М.М., Полякова А.С., Селимзянова Л.Р., Таточенко В.К., Старовойтова Е.В., Стецюк О.У., Федосеенко М.В., Чащина И.Л., Харькин А.В., 20232023Баранов А.А., Козлов Р.С., Намазова-Баранова Л.С., Андреева И.В., Бакрадзе М.Д., Вишнёва Е.А., Карасева М.С., Кузнецова Т.А., Куличенко Т.В., Лашкова Ю.С., Лютина Е.И., Манеров Ф.К., Маянский Н.А., Платонова М.М., Полякова А.С., Селимзянова Л.Р., Таточенко В.К., Старовойтова Е.В., Стецюк О.У., Федосеенко М.В., Чащина И.Л., Харькин А.В.Baranov A.A., Kozlov R.S., Namazova-Baranova L.S., Andreeva I.V., Bakradze M.D., Vishneva E.A., Karaseva M.S., Kuznetsova T.A., Kulichenko T.V., Lashkova Y.S., Lyutina E.I., Manerov F.K., Mayanskiy N.A., Platonova M.M., Polyakova A.S., Selimzyanova L.R., Tatochenko V.K., Starovoytova E.V., Stetsiouk O.U., Fedoseenko M.V., Chashchina I.L., Kharkin A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/2260

Экспертами Союза педиатров России разработаны актуальные клинические рекомендации по оказанию медицинской помощи детям с внебольничными пневмониями, которые были одобрены Научно-практическим советом Минздрава России в январе 2022 г. Особое внимание уделено этиологической структуре, современной классификации, диагностическим исследованиям и основным подходам к антибактериальной терапии внебольничной пневмонии у детей, основанным на принципах доказательной медицины. 

Experts of The Union of Pediatricians of Russia have developed current clinical guidelines for management of children with community-acquired pneumonia, which were approved by the Scientific and Practice Council of Ministry of Public Health of the Russian Federation in January 2022. Particular attention is paid to the etiological structure, modern classification, diagnostic tests and flagship approaches to antibacterial therapy of community-acquired pneumonia in children based on the principles of evidentiary medicine. 

детивнебольничная пневмонияклинические рекомендацииchildrencommunity-acquired pneumoniaclinical guidelinesReferencesГеппе Н.А., Розинова Н.Н., Волков И.К., Мизерницкий Ю.Л. Рабочая классификация основных клинических форм бронхолегочных заболеваний у детей // Трудный пациент. — 2009. — Т. 7. — № 1-2. — С. 35–39.Geppe NA, Rozinova NN, Volkov IK, Mizernitskii YuL. Rabochaya klassifikatsiya osnovnykh klinicheskikh form bronkholegochnykh zabolevanii u detei. Trudnyi patsient. 2009;7(1-2):35–39. (In Russ).Bradley JS, Byington CL, Shah SS, et al. Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):617–630. doi: https://doi.org/10.1093/cid/cir625Bradley JS, Byington CL, Shah SS, et al. Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):617–630. doi: https://doi.org/10.1093/cid/cir625Pocket book of hospital care for children: Guidelines for the management of common childhood illnesses. 2nd ed. Geneva: World Health Organization; 2013.Pocket book of hospital care for children: Guidelines for the management of common childhood illnesses. 2nd ed. Geneva: World Health Organization; 2013.Внебольничная пневмония у детей: клинические рекомендации / Российское респираторное общество; Межрегиональное педиатрическое респираторное общество; Федерация педиатров стран СНГ; Московское общество детских врачей. — М.: Оригинал-макет; 2015. — 64 с.Vnebol’nichnaya pnevmoniya u detei: Clinical guidelines. Russian Respiratory Society; Interregional Pediatric Respiratory Society; Federation of Pediatricians of the CIS countries; Moscow Society of Pediatric Doctors. Moscow: Original-maket; 2015. 64 p. (In Russ).Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113(4):701–707. doi: https://doi.org/10.1542/peds.113.4.701Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113(4):701–707. doi: https://doi.org/10.1542/peds.113.4.701Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835–845. doi: https://doi.org/10.1056/NEJMoa1405870Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835–845. doi: https://doi.org/10.1056/NEJMoa1405870Yun KW, Wallihan R, Juergensen A, et al. Community-Acquired Pneumonia in Children: Myths and Facts. Am J Perinatol. 2019;36(S02):S54–S57. doi: https://doi.org/10.1055/s-0039-1691801Yun KW, Wallihan R, Juergensen A, et al. CommunityAcquired Pneumonia in Children: Myths and Facts. Am J Perinatol. 2019;36(S02):S54–S57. doi: https://doi.org/10.1055/s-0039-1691801Kaz SE, Wiliams D. Pediatric community-acquired pneumonia in the United States: changing epidemiology, diagnostic and therapeutic challenges, and areas for future research. Infect Dis Clin North Am. 2018;32(1):47–63. doi: https://doi.org/10.1016/j.idc.2017.11.002Kaz SE, Wiliams D. Pediatric community-acquired pneumonia in the United States: changing epidemiology, diagnostic and therapeutic challenges, and areas for future research. Infect Dis Clin North Am. 2018;32(1):47–63. doi: https://doi.org/10.1016/j.idc.2017.11.002Gareca Perales J, Soleto Ortiz L, Loayza Mafayle R, et al. Diagnosis of Community-acquired Pneumonia in Hospitalized Children. A Multicenter Experience in Bolivia. Pediatr Infect Dis J. 2021;40(1):32–38. doi: https://doi.org/10.1097/INF.0000000000002909Gareca Perales J, Soleto Ortiz L, Loayza Mafayle R, et al. Diagnosis of Community-acquired Pneumonia in Hospitalized Children. A Multicenter Experience in Bolivia. Pediatr Infect Dis J. 2021;40(1):32–38. doi: https://doi.org/10.1097/INF.0000000000002909Rhedin S, Lindstrand A, Hjelmgren A, et al. Respiratory viruses associated with community-acquired pneumonia in children. Matched Case-Control study. Thorax. 2015;70(9):847–853. doi: https://doi.org/10.1136/thoraxjnl-2015-206933Rhedin S, Lindstrand A, Hjelmgren A, et al. Respiratory viruses associated with community-acquired pneumonia in children. Matched Case-Control study. Thorax. 2015;70(9):847–853. doi: https://doi.org/10.1136/thoraxjnl-2015-206933Таточенко В.К., Федоров А.М., Краснов М.В. и др. Острые пневмонии у детей / под ред. В.К. Таточенко. — Чебоксары: Издательство Чувашского университета; 1994. — 323 с.Tatochenko VK, Fedorov AM, Krasnov MV, et al. Ostrye pnevmonii u detei. Tatochenko VK, ed. Cheboksary: Chuvash University Press; 1994. 323 p. (In Russ).Pritt BS, Aubry MC. Histopathology of viral infections of the lung. Semin Diagn Pathol. 2017;34(6):510–517. doi: https://doi.org/10.1053/j.semdp.2017.06.005Pritt BS, Aubry MC. Histopathology of viral infections of the lung. Semin Diagn Pathol. 2017;34(6):510–517. doi: https://doi.org/10.1053/j.semdp.2017.06.005Самсонова М.В., Черняев А.Л., Михалева Л.М. и др. Патологическая анатомия легких при СOVID-19. Доступно по: https://patologoanatom.belzdrav.ru/upload/0_patologoanatom/covid-19/0605/mv_samsonova_covid-19_.pdf. Ссылка активна на 14.02.2022.Samsonova MV, Chernyaev AL, Mikhaleva LM, et al. Patologicheskaya anatomiya legkikh pri COVID-19. (In Russ). https://patologoanatom.belzdrav.ru/upload/0_patologoanatom/covid-19/0605/mv_samsonova_covid-19_.pdf.Stoll BJ, Hansen NI, Higgins RD, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002–2003. Pediatr Infect Dis J. 2005;24(7):635–639. doi: https://doi.org/10.1097/01.inf.0000168749.82105.64Stoll BJ, Hansen NI, Higgins RD, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002–2003. Pediatr Infect Dis J. 2005;24(7):635–639. doi: https://doi.org/10.1097/01.inf.0000168749.82105.64Mishaan AM, Mason EO Jr, Martinez-Aguilar G, et al. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J. 2005;24(3):201–206. doi: https://doi.org/10.1097/01.inf.0000151107.29132.70Mishaan AM, Mason EO Jr, Martinez-Aguilar G, et al. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J. 2005;24(3):201–206. doi: https://doi.org/10.1097/01.inf.0000151107.29132.70Proportions of child death by cause: Global Health Observatory. Geneva: World Health Organization; 2014.Proportions of child death by cause: Global Health Observatory. Geneva: World Health Organization; 2014.Kucova P, Kantor L, Fiserova K, et al. Bacterial Pathogens and Evaluation of a Cut-Off for Defining Early and Late Neonatal Infection. Antibiotics (Basel). 2021;10(3):278. doi: https://doi.org/10.3390/antibiotics10030278Kucova P, Kantor L, Fiserova K, et al. Bacterial Pathogens and Evaluation of a Cut-Off for Defining Early and Late Neonatal Infection. Antibiotics (Basel). 2021;10(3):278. doi: https://doi.org/10.3390/antibiotics10030278Nascimento-Carvalho CM, Ribeiro CT, Cardoso MR, et al. The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J. 2008;27(10):939–941. doi: https://doi.org/10.1097/INF.0b013e3181723751Nascimento-Carvalho CM, Ribeiro CT, Cardoso MR, et al. The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J. 2008;27(10):939–941. doi: https://doi.org/10.1097/INF.0b013e3181723751American Academy of Pediatrics Committee on Infectious Diseases. Recommended childhood and adolescent immunization schedules — United States, 2009. Pediatrics. 2009;123(1):189– 190. doi: https://doi.org/10.1542/peds.2008-3306American Academy of Pediatrics Committee on Infectious Diseases. Recommended childhood and adolescent immunization schedules — United States, 2009. Pediatrics. 2009;123(1):189– 190. doi: https://doi.org/10.1542/peds.2008-3306Tsolia MN, Psarras S, Bossios A, et al. Etiology of communityacquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis. 2004;39(5):681–686. doi: https://doi.org/10.1086/422996Tsolia MN, Psarras S, Bossios A, et al. Etiology of communityacquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis. 2004;39(5):681–686. doi: https://doi.org/10.1086/422996Tajima T, Nakayama E, Kondo Y, et al. Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children. J Infect Chemother. 2006;12(6):372–379. doi: https://doi.org/10.1007/s10156-006-0476-5Tajima T, Nakayama E, Kondo Y, et al. Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children. J Infect Chemother. 2006;12(6):372–379. doi: https://doi.org/10.1007/s10156-006-0476-5Marangu D, Zar HJ. Childhood pneumonia in low-and-middleincome countries: An update. Paediatr Respir Rev. 2019;32:3–9. doi: https://doi.org/10.1016/j.prrv.2019.06.001Marangu D, Zar HJ. Childhood pneumonia in low-and-middleincome countries: An update. Paediatr Respir Rev. 2019;32:3–9. doi: https://doi.org/10.1016/j.prrv.2019.06.001Esposito S, Patria MF, Tagliabue C, et al. CAP in chil-dren. In: European Respiratory Monograph 63: Community-Acquired Pneumonia. Chalmers J, Pletz M, Aliberti S, eds. 2014. pp. 130– 139.Esposito S, Patria MF, Tagliabue C, et al. CAP in chil-dren. In: European Respiratory Monograph 63: Community-Acquired Pneumonia. Chalmers J, Pletz M, Aliberti S, eds. 2014. pp. 130– 139.Кузьменков А.Ю., Трушин И.В., Авраменко А.А. и др. AMRmap: Интернет-платформа мониторинга антибиотикорезистентности // Клиническая микробиология и антимикробная химиотерапия. — 2017. — Т. 19. — № 2. — С. 84–90.Kuzmenkov AYu, Trushin IV, Avramenko AA, et al. AMRmap: an online platform for monitoring antibiotic resistance. Clinical Microbiology and Antimicrobial Chemotherapy. 2017;19(2):84–90. (In Russ).Баранов А.А., Намазова Л.С., Таточенко В.К. Пневмококковая инфекция и связанные с ней заболевания — серьезная проблема современного здравоохранения // Педиатрическая фармакология. — 2008. — Т. 5. — № 1. — С. 7–12.Baranov A, Namazova L, Tatochenko V. Pneumococcal infection and associated diseases — a serious problem of modern health care. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2008;5(1):7–12. (In Russ).Козлов Р.С., Синопальников А.И., Зайцева О.В. и др. Ингибиторозащищенный амоксициллин с повышенным содержанием амоксициллина и соотношением действующих компонентов 14:1: место в лечении внебольничных инфекций дыхательных путей и ЛОР-органов у детей. Резолюция Экспертного совета // Клинический разбор в общей медицине. — 2021. — № 2. — С. 6–14. — doi: https://doi.org/10.47407/kr2021.2.1.00036.Kozlov RS, Sinopalnikov AI, Zaitseva OV, et al. Inhibitor-protected amoxicillin with increased amoxicillin content and active ingredients ratio of 14:1: the use for treatment of community-acquired respiratory infections and ENT infections in children. Expert Council resolution. Clinical Review for General Practice. 2021;2:6–14. (In Russ). doi: https://doi.org/10.47407/kr2021.2.1.00036Torumkuney D, Mayanskiy N, Edelstein M, et al. Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Russia. J Antimicrob Chemother. 2018;73(Suppl_5):v14–v21. doi: https://doi.org/10.1093/jac/dky065Torumkuney D, Mayanskiy N, Edelstein M, et al. Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Russia. J Antimicrob Chemother. 2018;73(Suppl_5):v14–v21. doi: https://doi.org/10.1093/jac/dky065Иванова О.В., Эйдельштейн И.А., Ромашов О.И., Козлов Р.С. Оценка влияния мутаций в гене 23S рРНК Mycoplasma pneumoniae, обуславливающих устойчивость к макролидам, на тяжесть течения внебольничной пневмонии у лиц молодого возраста, находившихся на лечении в Смоленском военном госпитале // Клиническая микробиология и антимикробная химиотерапия. — 2020. — Т. 22. — № 4. — С. 306–312. — doi: https://doi.org/10.36488/cmac.2020.4.306-312Ivanova OV, Edelstein IA, Romashov OI, Kozlov RS. Effect of 23S rRNA gene mutations in Mycoplasma pneumoniae on severity of community-acquired pneumonia in young adult patients treated at the Smolensk military hospital. Clinical Microbiology and Antimicrobial Chemotherapy. 2020;22(4):306–312. (In Russ). doi: https://doi.org/10.36488/cmac.2020.4.306-312Анализ распространенности мутаций резистентности к макролидам и фторхинолонам у Mycoplasma genitalium и Mycoplasma pneumoniae // AMRcloud. — 08 апреля 2021. [Prevalence of macrolide and fluoroquinolone resistancemediating mutations in Mycoplasma genitalium and Mycoplasma pneumoniae. In: AMRcloud. April 08, 2021. (In Russ).] Доступно по: https://amrcloud.net/ru/project/demares. Ссылка активна на 14.02.2022.Prevalence of macrolide and fluoroquinolone resistancemediating mutations in Mycoplasma genitalium and Mycoplasma pneumoniae. In: AMRcloud. April 08, 2021. (In Russ). https://amrcloud.net/ru/project/demares. Ссылка активна на 14.02.2022.Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ. 2004;82(12):895–903.Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ. 2004;82(12):895–903.Заболеваемость населения России в 2000–2009 гг. Статистические материалы МЗСР РФ.The incidence of the population of Russia in 2000–2009. Statistical materials of the Ministry of Health and Social Development of the Russian Federation. (In Russ).Козлов Р.С., Кречикова О.И., Муравьев А.А. и др. Результаты исследования распространенности в России внебольничной пневмонии и острого среднего отита у детей в возрасте до 5 лет (PAPIRUS). Роль S. pneumoniae и H. influenzae в этиологии данных заболеваний // Клиническая микробиология и антимикробная химиотерапия. — 2013. — Т. 15. — № 4. — С. 246– 260.Kozlov RS, Krechikova OI, Muravyev AA, et al. Incidence of Community-Acquired Pneumonia and Acute Otitis Media in Children 0–5 Years in Russia and Role of S. pneumoniae or H. influenzae in the Etiology of the Diseases. Clinical Microbiology and Antimicrobial Chemotherapy. 2013;15(4):246–260. (In Russ).Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66 Suppl 2;ii1–23. doi: https://doi.org/10.1136/thoraxjnl-2011-200598Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66 Suppl 2;ii1–23. doi: https://doi.org/10.1136/thoraxjnl-2011-200598Levels and trends in child mortality: Report 2014. United Nations Inter Agency Group for Child Mortality Estimation. UNICEF, WHO, The World Bank, United Nations Population Divisoin. New York; 2014.Levels and trends in child mortality: Report 2014. United Nations Inter Agency Group for Child Mortality Estimation. UNICEF, WHO, The World Bank, United Nations Population Divisoin. New York; 2014.Revised WHO classification and treatment of childhood pneumonia at health facilities: evidence summaries. Geneva: World Health Organization; 2014.Revised WHO classification and treatment of childhood pneumonia at health facilities: evidence summaries. Geneva: World Health Organization; 2014.Wingerter SL, Bachur RG, Monuteaux MC, Neuman MI. Application of the World Health Organization criteria to predict radiographic pneumonia in a US-based pediatric emergency department. Pediatr Infect Dis J. 2012;31(6):561–564. doi: https://doi.org/10.1097/INF.0b013e31824da716Wingerter SL, Bachur RG, Monuteaux MC, Neuman MI. Application of the World Health Organization criteria to predict radiographic pneumonia in a US-based pediatric emergency department. Pediatr Infect Dis J. 2012;31(6):561–564. doi: https://doi.org/10.1097/INF.0b013e31824da716Таточенко В.К. Болезни органов дыхания у детей. — 7-е изд. — М.: Боргес; 2019. — 300 с.Tatochenko VK. Bolezni organov dykhaniya u detei. 7th ed. Moscow: Borges; 2019. 300 p. (In Russ).Rambaud-Althaus C, Althaus F, Genton B, D’Acremont V. Clinical features for diagnosis of pneumonia in children younger than 5 years: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(4):439–450. doi: https://doi.org/10.1016/S1473-3099(15)70017-4.Rambaud-Althaus C, Althaus F, Genton B, D’Acremont V. Clinical features for diagnosis of pneumonia in children younger than 5 years: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(4):439–450. doi: https://doi.org/10.1016/S1473-3099(15)70017-4.Ginsburg AS, Lenahan JL, Izadnegahdar R, Ansermino JM. A Systematic Review of Tools to Measure Respiratory Rate in Order to Identify Childhood Pneumonia. Am J Respir Crit Care Med. 2018;197(9):1116–1127. doi: https://doi.org/10.1164/rccm.201711-2233CIGinsburg AS, Lenahan JL, Izadnegahdar R, Ansermino JM. A Systematic Review of Tools to Measure Respiratory Rate in Order to Identify Childhood Pneumonia. Am J Respir Crit Care Med. 2018;197(9):1116–1127. doi: https://doi.org/10.1164/rccm.201711-2233CIBoyd K. Back to the Basics: Community-Acquired Pneumonia in Children. Pediatr Ann. 2017;46(7):e257–e261. doi: https://doi.org/10.3928/19382359-20170616-01Boyd K. Back to the Basics: Community-Acquired Pneumonia in Children. Pediatr Ann. 2017;46(7):e257–e261. doi: https://doi.org/10.3928/19382359-20170616-01Søndergaard MJ, Friis MB, Hansen DS, Jørgensen IM.. Clinical manifestations in infants and children with Mycoplasma pneumoniae infection. PLoS One. 2018;13(4):e0195288. doi: https://doi.org/10.1371/journal.pone.0195288Søndergaard MJ, Friis MB, Hansen DS, Jørgensen IM.. Clinical manifestations in infants and children with Mycoplasma pneumoniae infection. PLoS One. 2018;13(4):e0195288. doi: https://doi.org/10.1371/journal.pone.0195288Манеров Ф.К. Диагностика и терапия острой пневмонии у детей при разных вариантах течения: дис. … докт. мед. наук. — Новокузнецк; 1990.Manerov FK. Diagnostika i terapiya ostroi pnevmonii u detei pri raznykh variantakh techeniya. [dissertation]. Novokuznetsk; 1990. (In Russ).Таточенко В.К. Внебольничные пневмонии у детей — проблемы и решения // Российский вестник перинатологии и педиатрии. — 2021. — Т. 66. — № 1. — С. 9–21. — doi: https://doi.org/10.21508/1027-4065-2021-66-1-9-21Tatochenko VK. Community-acquired pneumonia in children — problems and solutions. Rossiyskiy Vestnik Perinatologii i Pediatrii = Russian Bulletin of Perinatology and Pediatrics. 2021;66(1):9–21. (In Russ). doi: https://doi.org/10.21508/1027-4065-2021-66-1-9-21Mcintosh K. Community-Acquired pneumonia in children. N Engl J Med. 2002; 346(6): 429–437. doi: https://doi.org/10.1056/NEJMra011994Mcintosh K. Community-Acquired pneumonia in children. N Engl J Med. 2002; 346(6): 429–437. doi: https://doi.org/10.1056/NEJMra011994Crawford SE, Daum RS. Bacterial pneumonia, lung abscess and empyema. In: Pediatric respiratory medicine. Taussig LM, Landau LI, eds. 2nd ed. Mosby, Inc.; 2008. pp. 501–553. doi: https://doi.org/10.1016/B978-032304048-8.50039-6Crawford SE, Daum RS. Bacterial pneumonia, lung abscess and empyema. In: Pediatric respiratory medicine. Taussig LM, Landau LI, eds. 2nd ed. Mosby, Inc.; 2008. pp. 501–553. doi: https://doi.org/10.1016/B978-032304048-8.50039-6Бакрадзе М.Д., Куличенко Т.В., Митюшин И.Л. и др. Лихорадящий ребенок / под ред. А.А. Баранова. — М.: ПедиатрЪ; 2017. — 320 с.Bakradze MD, Kulichenko TV, Mityushin IL, et al. Likhoradyashchii rebenok. Baranova AA, et al. Moscow: Pediatr; 2017. 320 p. (In Russ).Goodman D, Crocker ME, Pervaiz F. Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group. Lancet Respir Med. 2019;7(12):1068–1083. doi: https://doi.org/10.1016/S2213-2600(19)30249-8Goodman D, Crocker ME, Pervaiz F. Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group. Lancet Respir Med. 2019;7(12):1068–1083. doi: https://doi.org/10.1016/S2213-2600(19)30249-8Thomas J, Pociute A, Kevalas R, et al. Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review. Ital J Pediatr. 2020;46(1):4. doi: https://doi.org/10.1186/s13052-020-0770-3Thomas J, Pociute A, Kevalas R, et al. Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review. Ital J Pediatr. 2020;46(1):4. doi: https://doi.org/10.1186/s13052-020-0770-3Iroh Tam PY, Bernstein E, Ma X, Ferrieri P. Blood Culture in Evaluation of Pediatric Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Hosp Pediatr. 2015;5(6):324–336. doi: https://doi.org/10.1542/hpeds.2014-0138Iroh Tam PY, Bernstein E, Ma X, Ferrieri P. Blood Culture in Evaluation of Pediatric Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Hosp Pediatr. 2015;5(6):324–336. doi: https://doi.org/10.1542/hpeds.2014-0138Bhuiyan MU, Blyth CC, West R. Combination of clinical symptoms and blood biomarkers can improve discrimination between between bacterial or viral community-acquired pneumonia in children. BMC Pulm Med. 2019;19(1):71. doi: https://doi.org/10.1186/s12890-019-0835-5Bhuiyan MU, Blyth CC, West R. Combination of clinical symptoms and blood biomarkers can improve discrimination between between bacterial or viral community-acquired pneumonia in children. BMC Pulm Med. 2019;19(1):71. doi: https://doi.org/10.1186/s12890-019-0835-5ERS handbook of paediatric respiratory medicine. Eber E, Midulla F, eds. Sheffield: European Respiratory Society; 2013. 719 p.ERS handbook of paediatric respiratory medicine. Eber E, Midulla F, eds. Sheffield: European Respiratory Society; 2013. 719 p.Hosseini SM, Poorolajal J, Karami M, Ameri P. Prevalence of Nasopharyngeal Carriage of Streptococcus pneumonia in Iran: A Meta-Analysis. J Res Health Sci. 2015;15(3):141–146.Hosseini SM, Poorolajal J, Karami M, Ameri P. Prevalence of Nasopharyngeal Carriage of Streptococcus pneumonia in Iran: A Meta-Analysis. J Res Health Sci. 2015;15(3):141–146.Johnson HL, Deloria-Knoll M, Levine OS, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7(10):e1000348. doi: https://doi.org/10.1371/journal.pmed.1000348Johnson HL, Deloria-Knoll M, Levine OS, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7(10):e1000348. doi: https://doi.org/10.1371/journal.pmed.1000348Fernando M de Benedictis FM, Kerem E, Chang AB, et al. Complicated pneumonia in children. Lancet. 2020;396(10253):786– 798. doi: https://doi.org/10.1016/S0140-6736(20)31550-6Fernando M de Benedictis FM, Kerem E, Chang AB, et al. Complicated pneumonia in children. Lancet. 2020;396(10253):786– 798. doi: https://doi.org/10.1016/S0140-6736(20)31550-6Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19): временные методические рекомендации. Версия 11 от 07.05.2021.Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19): temporary guidelines. Version 11 from 05/07/2021 (In Russ).Особенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (COVID-19) у детей: методические рекомендации. Версия 2 от 03.07.2021.Osobennosti klinicheskikh proyavlenii i lecheniya zabolevaniya, vyzvannogo novoi koronavirusnoi infektsiei (COVID-19) u detei: temporary guidelines. Version 2 from 03/07/2021 (In Russ).Яцышина С.Б., Спичак Т.В., Ким С.С. и др. Выявление респираторных вирусов и атипичных бактерий у больных пневмонией и здоровых детей за десятилетний период наблюдения // Педиатрия. Журнал им. Г.Н. Сперанского. — 2016. — Т. 95. — № 2. — С. 43–50.Uchaykin VF, Spichak TV, Kim SS, et al. Revealing of respiratory viruses and atypical bacteria in children with pneumonia and healthy children for ten years of observation. Pediatria. Journal n.a. G.N. Speransky. 2016;95(2):43–50. (In Russ).Spuesens EB, Fraaij PL, Visser EG, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444. doi: https://doi.org/10.1371/journal.pmed.1001444Spuesens EB, Fraaij PL, Visser EG, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444. doi: https://doi.org/10.1371/journal.pmed.1001444Copete AR, Vera C, Herrera M, et al. Mycoplasma pneumoniae in children with and without community-acquired pneumonia. What do PCR and serology say? Pediatr Infect Dis J. 2020;39(7):e104– e108. doi: https://doi.org/10.1097/INF.0000000000002636.Copete AR, Vera C, Herrera M, et al. Mycoplasma pneumoniae in children with and without community-acquired pneumonia. What do PCR and serology say? Pediatr Infect Dis J. 2020;39(7):e104– e108. doi: https://doi.org/10.1097/INF.0000000000002636.Guiso N, Berbers G, Fry NK, et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis. 2011;30(3):307–312. doi: https://doi.org/10.1007/s10096-010-1104-yGuiso N, Berbers G, Fry NK, et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis. 2011;30(3):307–312. doi: https://doi.org/10.1007/s10096-010-1104-yDean P, Florin TA. Factors Associated With Pneumonia Severity in Children: A Systematic Review. J Pediatric Infect Dis Soc. 2018;7(4):323–334. doi: https://doi.org/10.1093/jpids/piy046Dean P, Florin TA. Factors Associated With Pneumonia Severity in Children: A Systematic Review. J Pediatric Infect Dis Soc. 2018;7(4):323–334. doi: https://doi.org/10.1093/jpids/piy046Andronikou S, Lambert E, Halton J, et al. Guidelines for the use of chest radiographs in community-acquired pneumonia in children and adolescents. Pediatr Radiol. 2017;47(11):1405–1411. doi: https://doi.org/10.1007/s00247-017-3944-4Andronikou S, Lambert E, Halton J, et al. Guidelines for the use of chest radiographs in community-acquired pneumonia in children and adolescents. Pediatr Radiol. 2017;47(11):1405–1411. doi: https://doi.org/10.1007/s00247-017-3944-4Le Roux DM, Zar HJ. Community-acquired pneumonia in children — a changing spectrum of disease. Pediatr Radiol. 2017;47(11):1392–1398. doi: https://doi.org/10.1007/s00247-017-3827-8Le Roux DM, Zar HJ. Community-acquired pneumonia in children — a changing spectrum of disease. Pediatr Radiol. 2017;47(11):1392–1398. doi: https://doi.org/10.1007/s00247-017-3827-8Levinsky Y, Mimouni FB, Fisher D, Ehrlichman M. Chest radiography of acute paediatric lower respiratory infections: experience versus interobserver variation. Acta Paediatr. 2013;102(7):e310–e314. doi: https://doi.org/10.1111/apa.12249Levinsky Y, Mimouni FB, Fisher D, Ehrlichman M. Chest radiography of acute paediatric lower respiratory infections: experience versus interobserver variation. Acta Paediatr. 2013;102(7):e310–e314. doi: https://doi.org/10.1111/apa.12249Nascimento-Carvalho CM, Araújo-Neto CA, Ruuskanen O. Association between bacterial infection and radiologically confirmed pneumonia among children. Pediatr Infect Dis J. 2015;34(5):490– 493. doi: https://doi.org/10.1097/INF.0000000000000622Nascimento-Carvalho CM, Araújo-Neto CA, Ruuskanen O. Association between bacterial infection and radiologically confirmed pneumonia among children. Pediatr Infect Dis J. 2015;34(5):490– 493. doi: https://doi.org/10.1097/INF.0000000000000622Novack V, Avnon LS, Smolyakov A, et al. Disagreement in the interpretation of chest radiographs among specialists and clinical outcomes of patients hospitalized with suspected pneumonia. EurJ Intern Med. 2006;17(1):43–47. doi: https://doi.org/10.1016/j.ejim.2005.07.008Novack V, Avnon LS, Smolyakov A, et al. Disagreement in the interpretation of chest radiographs among specialists and clinical outcomes of patients hospitalized with suspected pneumonia. EurJ Intern Med. 2006;17(1):43–47. doi: https://doi.org/10.1016/j.ejim.2005.07.008Johnson J, Kline JA. Intraobserver and interobserver agreement of the interpretation of pediatric chest radiographs. Emerg Radiol. 2010;17(4):285–290. doi: https://doi.org/10.1007/s10140-009-0854-2Johnson J, Kline JA. Intraobserver and interobserver agreement of the interpretation of pediatric chest radiographs. Emerg Radiol. 2010;17(4):285–290. doi: https://doi.org/10.1007/s10140-009-0854-2Weigl J. Community acquired pneumonia in Germany. In: 21th Annual Meeting of ESPID, Taormina, Sicily, April 9–12, 2003. Abstr. 47. p. 24.Weigl J. Community acquired pneumonia in Germany. In: 21th Annual Meeting of ESPID, Taormina, Sicily, April 9–12, 2003. Abstr. 47. p. 24.Orso D, Ban A, Guglielmo N. Lung ultrasound in diagnosing pneumonia in childhood: a systematic review and meta-analysis. J Ultrasound. 2018;21(3):183–195. doi: https://doi.org/10.1007/s40477-018-0306-5Orso D, Ban A, Guglielmo N. Lung ultrasound in diagnosing pneumonia in childhood: a systematic review and meta-analysis. J Ultrasound. 2018;21(3):183–195. doi: https://doi.org/10.1007/s40477-018-0306-5El Fahimi N, Calleja MA, Ratnayake L, Ali I. Audit of a multidisciplinary approach to improve management of communityacquired pneumonia. Eur J Hosp Pharm. 2019;26(4):223–225. doi: https://doi.org/10.1136/ejhpharm-2017-001368El Fahimi N, Calleja MA, Ratnayake L, Ali I. Audit of a multidisciplinary approach to improve management of communityacquired pneumonia. Eur J Hosp Pharm. 2019;26(4):223–225. doi: https://doi.org/10.1136/ejhpharm-2017-001368Lodha R, Kabra SK, Pandey RM. Antibiotics for communityacquired pneumonia in children. Cochrane Database Syst Rev. 2013;2013(6):CD004874. doi: https://doi.org/10.1186/1471-2431-9-15Lodha R, Kabra SK, Pandey RM. Antibiotics for communityacquired pneumonia in children. Cochrane Database Syst Rev. 2013;2013(6):CD004874. doi: https://doi.org/10.1186/1471- 2431-9-15Infants and Children: Acute Management of Community Acquired Pneumonia: Guideline. NSW Health; 2018. Available online: https://www1.health.nsw.gov.au/pds/ActivePDSDocuments/GL2018_007.pdf. Accessed on February 15, 2023.Infants and Children: Acute Management of Community Acquired Pneumonia: Guideline. NSW Health; 2018. Available online: https://www1.health.nsw.gov.au/pds/ActivePDSDocuments/GL2018_007.pdf. Accessed on February 15, 2023.Амоксициллин Диспертаб®. Регистрационное удостоверение № ЛП-006567. Дата регистрации: 13.11.2022 // Государственный реестр лекарственных средств: официальный сайт. Доступно по: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=3235dc2e-7f7b-4d14-875dfe3e1d5a66b1. Ссылка активна на 02.02.2023.Amoxicillin Dispertab®. Registration certificate No. ЛП-006567. Registration date: November 13, 2022. In: State Register of Medicines: official website. (In Russ). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=3235dc2e-7f7b-4d14-875dfe3e1d5a66b1.Амосин®. Регистрационное удостоверение № ЛС-001736. Дата регистрации: 13.08.2010 // Государственный реестр лекарственных средств: официальный сайт. Доступно по: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=55024c57-ba7a-4584-bfa7-a1a0ab61da4d. Ссылка активна на 02.02.2023.Amosin®. Registration certificate No. ЛС-001736. Registration date: August 13, 2010. In: State Register of Medicines: official website. (In Russ). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=55024c57-ba7a-4584-bfa7-a1a0ab61da4d.Aurangzeb B., Hameed A. Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of communityacquired pneumonia in children. J Coll Physicians Surg Pak. 2003;13(12):704–707.Aurangzeb B., Hameed A. Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of communityacquired pneumonia in children. J Coll Physicians Surg Pak. 2003;13(12):704–707.Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J. 1999;18(2):98–104. doi: https://doi.org/10.1097/00006454-199902000-00004Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J. 1999;18(2):98–104. doi: https://doi.org/10.1097/00006454-199902000-00004Schönwald S, Gunjaca M, Kolacny-Babić L, et al. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. J Antimicrob Chemother. 1990;25 Suppl A:123–126. doi: https://doi.org/10.1093/jac/25.suppl_a.123Schönwald S, Gunjaca M, Kolacny-Babić L, et al. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. J Antimicrob Chemother. 1990;25 Suppl A:123–126. doi: https://doi.org/10.1093/jac/25.suppl_a.123Ушкалова Е.А. Применение доксициклина у детей и подростков // Фарматека. — 2005. — № 15. — С. 18.Ushkalova EA. Primenenie doksitsiklina u detei i podrostkov. Farmateka. 2005;(15):18. (In Russ).Chiappini E, Mazzantini R, Bruzzese E, et al. Rational use of antibiotics for the management of children’s respiratory tract infections in the ambulatory setting: an evidence-based consensus by the Italian Society of Preventive and Social Pediatrics. Paediatr Respir Rev. 2014;15(3):231–236. doi: https://doi.org/10.1016/j.prrv.2013.11.011Chiappini E, Mazzantini R, Bruzzese E, et al. Rational use of antibiotics for the management of children’s respiratory tract infections in the ambulatory setting: an evidence-based consensus by the Italian Society of Preventive and Social Pediatrics. Paediatr Respir Rev. 2014;15(3):231–236. doi: https://doi.org/10.1016/j.prrv.2013.11.011Mathur S, Fuchs A, Bielicki J, et al. Antibiotic use for communityacquired pneumonia in neonates and children: WHO evidence review. Paediatr Int Child Health. 2018;38(Supp1):S66–S75. doi: https://doi.org/10.1080/20469047.2017.1409455Mathur S, Fuchs A, Bielicki J, et al. Antibiotic use for communityacquired pneumonia in neonates and children: WHO evidence review. Paediatr Int Child Health. 2018;38(Supp1):S66–S75. doi: https://doi.org/10.1080/20469047.2017.1409455Matsubara K, Morozumi M, Okada T, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother. 2009;15(6):380–383. doi: https://doi.org/10.1007/s10156-009-0715-7Matsubara K, Morozumi M, Okada T, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother. 2009;15(6):380–383. doi: https://doi.org/10.1007/s10156-009-0715-7Lee H, Yun KW, Lee HJ, Choi EH. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018;16(1):23–34. doi: https://doi.org/10.1080/14787210.2018.1414599Lee H, Yun KW, Lee HJ, Choi EH. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018;16(1):23–34. doi: https://doi.org/10.1080/14787210.2018.1414599Leung AKC, Wong AHC, Hon KL. Community-Acquired Pneumonia in Children. Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):136–144. doi: https://doi.org/10.2174/1872213X12666180621163821Leung AKC, Wong AHC, Hon KL. Community-Acquired Pneumonia in Children. Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):136–144. doi: https://doi.org/10.2174/187221 3X12666180621163821Цефуроксим. Регистрационное удостоверение № ЛП-000003. Дата регистрации: 02.03.2007 // Государственный реестр лекарственных средств: официальный сайт. Доступно по: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=ffcb5e06-1df5-4860-8d95-7bd11e4f869b. Ссылка активна на 02.02.2023.Cefuroxime. Registration certificate No. ЛП-000003. Registration date: Marth 02, 2007. State Register of Medicines: official website. (In Russ). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=ffcb5e06-1df5-4860-8d95-7bd11e4f869b.Haider BA, Saeed MA, Bhutta ZA. Short-course versus longcourse antibiotic therapy for non- severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev. 2008;(2):CD005976. doi: https://doi.org/10.1002/14651858.CD005976.pub2Haider BA, Saeed MA, Bhutta ZA. Short-course versus longcourse antibiotic therapy for non- severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev. 2008;(2):CD005976. doi: https://doi.org/10.1002/14651858.CD005976.pub2Зинфоро®. Регистрационное удостоверение № ЛП-001912. Дата регистрации: 20.11.2012 // Государственный реестр лекарственных средств: официальный сайт. Доступно по: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=8035dfec-e622-4f1e-b152-c429567cb058. Ссылка активна на 02.02.2023.Zinforo®. Registration certificate No. ЛП-001912. Registration date: November 20, 2012. State Register of Medicines: official website. (In Russ). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=8035dfec-e622-4f1e-b152-c429567cb058.Cannavino CR, Nemeth A, Korczowski B, et al. A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone. Pediatr Infect Dis J. 2016;35(7):752–759. doi: https://doi.org/10.1097/INF.0000000000001159Cannavino CR, Nemeth A, Korczowski B, et al. A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone. Pediatr Infect Dis J. 2016;35(7):752–759. doi: https://doi.org/10.1097/INF.0000000000001159Pneumonia (community-acquired): antimicrobial prescribing. NICE guideline [NG138]. September 2019. Available online: https://www.nice.org.uk/guidance/ng138. Accessed on February 15, 2023.Pneumonia (community-acquired): antimicrobial prescribing. NICE guideline [NG138]. September 2019. Available online: https://www.nice.org.uk/guidance/ng138. Accessed on February 15, 2023.Nascimento-Carvalho CM. Community-acquired pneumonia among children: the latest evidence for an updated management. J Pediatr (Rio J). 2020;96(Suppl 1):29–38. doi: https://doi.org/10.1016/j.jped.2019.08.003Nascimento-Carvalho CM. Community-acquired pneumonia among children: the latest evidence for an updated management. J Pediatr (Rio J). 2020;96(Suppl 1):29–38. doi: https://doi.org/10.1016/j.jped.2019.08.003Pernica JM, Harman S, Kam AJ, et al. Short-course antimicrobial therapy for pediatric community-acquired pneumonia. The SAFER randomized clinical trial. JAMA Pediatr. 2021;175(5):475–482. doi: https://doi.org/10.1001/jamapediatrics.2020.6735Pernica JM, Harman S, Kam AJ, et al. Short-course antimicrobial therapy for pediatric community-acquired pneumonia. The SAFER randomized clinical trial. JAMA Pediatr. 2021;175(5):475–482. doi: https://doi.org/10.1001/jamapediatrics.2020.6735Same RG, Amoah J, Hsu AJ, et al. The Association of Antibiotic Duration With Successful Treatment of Community-Acquired Pneumonia in Children. J Pediatric Infect Dis Soc. 2021;10(3):267– 273. doi: https://doi.org/10.1093/jpids/piaa055Same RG, Amoah J, Hsu AJ, et al. The Association of Antibiotic Duration With Successful Treatment of Community-Acquired Pneumonia in Children. J Pediatric Infect Dis Soc. 2021;10(3):267– 273. doi: https://doi.org/10.1093/jpids/piaa055Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis imroves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J. 2011;30(4):289– 294. doi: https://doi.org/10.1097/INF.0b013e3182002d14Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis imroves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J. 2011;30(4):289– 294. doi: https://doi.org/10.1097/INF.0b013e3182002d14Bradley JS, Ching DK, Hart CL. Invasive bacterial disease in childhood: efficacy of oral antibiotic therapy following short course parenteral therapy in non-central nervous system infections. Pediatr Infect Dis J. 1987;6(9):821–825.Bradley JS, Ching DK, Hart CL. Invasive bacterial disease in childhood: efficacy of oral antibiotic therapy following short course parenteral therapy in non-central nervous system infections. Pediatr Infect Dis J. 1987;6(9):821–825.Moreno-Pérez D, Andrés Martín A, Tagarro García A, et al. Community acquired pneumonia in children: Treatment of complicated cases and risk patients. Consensus statement by the Spanish Society of Paediatric Infectious Diseases (SEIP) and the Spanish Society of Paediatric Chest Diseases (SENP). An Pediatr (Barc). 2015;83(3):217.e1–11. doi: https://doi.org/10.1016/j.anpedi.2014.12.002Moreno-Pérez D, Andrés Martín A, Tagarro García A, et al. Community acquired pneumonia in children: Treatment of complicated cases and risk patients. Consensus statement by the Spanish Society of Paediatric Infectious Diseases (SEIP) and the Spanish Society of Paediatric Chest Diseases (SENP). An Pediatr (Barc). 2015;83(3):217.e1–11. doi: https://doi.org/10.1016/j.anpedi.2014.12.002Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;4:CD008965. doi: https://doi.org/10.1002/14651858.CD008965.pub3Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;4:CD008965. doi: https://doi.org/10.1002/14651858.CD008965.pub3Heneghan CJ, Onakpoya I, Jones MA, et al. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data. Health Technol Assess. 2016;20(42):1–242. doi: https://doi.org/10.3310/hta20420Heneghan CJ, Onakpoya I, Jones MA, et al. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data. Health Technol Assess. 2016;20(42):1–242. doi: https://doi.org/10.3310/hta20420Реленза. Регистрационное удостоверение № ЛСР000095. Дата регистрации: 31.05.2007 // Государственный реестр лекарственных средств: официальный сайт. Доступно по: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=5edcae9f-e8f3-4227-9939-e5aa7fdf1e9b. Ссылка активна на 02.02.2023.Relenza. Registration certificate No. ЛСР-000095. Registration date: May 31, 2007. State Register of Medicines: official website. (In Russ). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=5edcae9f-e8f3-4227-9939-e5aa7fdf1e9b.Thorlund K, Awad T, Boivin G, Thabane L. Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis. 2011;11:134. doi: https://doi.org/10.1186/1471-2334-11-134Thorlund K, Awad T, Boivin G, Thabane L. Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis. 2011;11:134. doi: https://doi.org/10.1186/1471-2334-11-134Нурофен® для детей. Регистрационное удостоверение № П N014745/01. Дата регистрации: 22.08.2008 // Государственный реестр лекарственных средств: официальный сайт. Доступно по: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=58ea2be8-b33b-4924-9fab97a5825084a6. Ссылка активна на 02.02.2023.Nurofen® for children. Registration certificate No. П N014745/01. Registration date: August 22, 2008. State Register of Medicines: official website. (In Russ). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=58ea2be8-b33b-4924-9fab97a5825084a6.Руководство по амбулаторно-клинической педиатрии / под ред. А.А. Баранова. — 2-е изд. — М.: ГЭОТАР-Медиа; 2009.Rukovodstvo po ambulatorno-klinicheskoi pediatrii. Baranov AA, ed. 2nd ed. Moscow: GEOTAR-Media; 2009. (In Russ).Feld LG, Neuspiel DR, Foster BA, et al. Clinical Practice Guideline: Maintenance Intravenous Fluids in Children. Pediatrics. 2018;142(6):e20183083. doi: https://doi.org/10.1542/peds.2018-3083Feld LG, Neuspiel DR, Foster BA, et al. Clinical Practice Guideline: Maintenance Intravenous Fluids in Children. Pediatrics. 2018;142(6):e20183083. doi: https://doi.org/10.1542/peds.2018-3083Duke T, Molyneux EM. Intravenous fluids for seriously ill children: time to reconsider. Lancet. 2003;362(9392):1320–1323. doi: https://doi.org/10.1016/S0140-6736(03)14577-1Duke T, Molyneux EM. Intravenous fluids for seriously ill children: time to reconsider. Lancet. 2003;362(9392):1320–1323. doi: https://doi.org/10.1016/S0140-6736(03)14577-1Barson WJ. Pneumonia in children: Inpatient treatment. In: UpToDate. Available online: https://www.uptodate.com/contents/pneumonia-in-children-inpatient-treatment?search=pneumonia%20acidosis&source=search_result&selectedTitle=2~150&usage_type=default. Accessed on February 15, 2023.Barson WJ. Pneumonia in children: Inpatient treatment. In: UpToDate. Available online: https://www.uptodate.com/contents/pneumonia-in-children-inpatient-treatment?search=pneumonia%20acidosis&source=search_result&selectedTitle=2~150&usage_type=default. Accessed on February 15, 2023.Ambroggio L, Test M, Metlay JP, et al. Adjunct Systemic Corticosteroid Therapy in Children With Community-Acquired Pneumonia in the Outpatient Setting. J Pediatric Infect Dis Soc. 2015;4(1):21–27. doi: https://doi.org/10.1093/jpids/piu017Ambroggio L, Test M, Metlay JP, et al. Adjunct Systemic Corticosteroid Therapy in Children With Community-Acquired Pneumonia in the Outpatient Setting. J Pediatric Infect Dis Soc. 2015;4(1):21–27. doi: https://doi.org/10.1093/jpids/piu017Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J. 1996;15(3):255– 259. doi: https://doi.org/10.1097/00006454-199603000-00015Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J. 1996;15(3):255– 259. doi: https://doi.org/10.1097/00006454-199603000-00015Chang CC, Cheng AC, Chang AB. Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults. Cochrane Database Syst Rev. 2014;(3):CD006088. doi: https://doi.org/10.1002/14651858. CD006088.pub2Chang CC, Cheng AC, Chang AB. Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults. Cochrane Database Syst Rev. 2014;(3):CD006088. doi: https://doi.org/10.1002/14651858. CD006088.pub2Stern A, Skalsky K, Avni T, et al. Corticosteroids for pneumonia. Cochrane Database Syst Rev. 2017;12(12):CD007720. doi: https://doi.org/10.1002/14651858.CD007720.pub3Stern A, Skalsky K, Avni T, et al. Corticosteroids for pneumonia. Cochrane Database Syst Rev. 2017;12(12):CD007720. doi: https://doi.org/10.1002/14651858.CD007720.pub3Tagarro A, Otheo E, Baquero-Artigao F, et al. Dexamethasone for parapneumonic pleural effusion: a randomized, double-blind, clinical trial. J Pediatr. 2017;185:117–23.e6. doi: https://doi.org/10.1016/j.jpeds.2017.02.043Tagarro A, Otheo E, Baquero-Artigao F, et al. Dexamethasone for parapneumonic pleural effusion: a randomized, double-blind, clinical trial. J Pediatr. 2017;185:117–23.e6. doi: https://doi.org/10.1016/j.jpeds.2017.02.043Das RR, Singh M, Naik SS. Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia. Cochrane Database Syst Rev. 2018;7(7):CD011597. doi: https://doi.org/10.1002/14651858.CD011597.pub2Das RR, Singh M, Naik SS. Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia. Cochrane Database Syst Rev. 2018;7(7):CD011597. doi: https://doi.org/10.1002/14651858.CD011597.pub2Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;2013(1):CD000980. doi: https://doi.org/10.1002/14651858.CD000980.pub4Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;2013(1):CD000980. doi: https://doi.org/10.1002/14651858.CD000980.pub4Padhani ZA, Moazzam Z, Ashraf A, et al. Vitamin C supplementation for prevention and treatment of pneumonia. Cochrane Database Syst Rev. 2020;4(4):CD013134. doi: https://doi.org/10.1002/14651858.CD013134.pub2Padhani ZA, Moazzam Z, Ashraf A, et al. Vitamin C supplementation for prevention and treatment of pneumonia. Cochrane Database Syst Rev. 2020;4(4):CD013134. doi: https://doi.org/10.1002/14651858.CD013134.pub2Wu T, Ni J, Wei J. Vitamin A for non‐measles pneumonia in children. Cochrane Database Syst Rev. 2005;2005(3):CD003700. doi: https://doi.org/10.1002/14651858.CD003700.pub2Wu T, Ni J, Wei J. Vitamin A for non‐measles pneumonia in children. Cochrane Database Syst Rev. 2005;2005(3):CD003700. doi: https://doi.org/10.1002/14651858.CD003700.pub2Brown N, Roberts C. Vitamin A for acute respiratory infection in developing countries: a meta‐analysis. Acta Paediatr. 2004;93(11):1437–1442. doi: https://doi.org/10.1080/08035250410022143Brown N, Roberts C. Vitamin A for acute respiratory infection in developing countries: a meta‐analysis. Acta Paediatr. 2004;93(11):1437–1442. doi: https://doi.org/10.1080/08035250410022143Kumar RM, Kabra SK, Singh M. Efficacy and acceptability of different modes of oxygen administration in children: implications for a community hospital. J Trop Pediatr. 1997;43(1):47–49. doi: https://doi.org/10.1093/tropej/43.1.47Kumar RM, Kabra SK, Singh M. Efficacy and acceptability of different modes of oxygen administration in children: implications for a community hospital. J Trop Pediatr. 1997;43(1):47–49. doi: https://doi.org/10.1093/tropej/43.1.47Carter E, Waldhausen J, Zhang W, et al. Management of children with empyema: pleural drainage is not always necessary. Pediatr Pulmonol. 2010;45(5):475–480. doi: https://doi.org/10.1002/ppul.21200Carter E, Waldhausen J, Zhang W, et al. Management of children with empyema: pleural drainage is not always necessary. Pediatr Pulmonol. 2010;45(5):475–480. doi: https://doi.org/10.1002/ppul.21200Малявин А.Г., Епифанов В.А., Глазкова И.И. Реабилитация при заболеваниях органов дыхания. — М.: ГЭОТАР-Медиа; 2010. — 352 с. — (Библиотека врача специалиста).Malyavin AG, Epifanov VA, Glazkova II. Reabilitatsiya pri zabolevaniyakh organov dykhaniya. Moscow: GEOTAR-Media; 2010. 352 p. (Biblioteka vracha-spetsialista). (In Russ).Swingler GH, Michaels D, Hussey GGD. Conjugate vaccines for preventing Haemophilus influenzae type B infections. Cochrane Database Syst Rev. 2003;(4):CD001729. doi: https://doi.org/10.1002/14651858.CD00172Swingler GH, Michaels D, Hussey GGD. Conjugate vaccines for preventing Haemophilus influenzae type B infections. Cochrane Database Syst Rev. 2003;(4):CD001729. doi: https://doi.org/10.1002/14651858.CD00172The Green Book. Immunization against infections disease. 2013. Part 2. Ch. 16. pp. 127–143.The Green Book. Immunization against infections disease. 2013. Part 2. Ch. 16. pp. 127–143.Cox AD, Barreto L, Ulanova M, et al. Developing a vaccine for Haemophilus influenzae serotype a: Proceedings of a workshop. Can Commun Dis Rep. 2017;43(5):89–95. doi: https://doi.org/10.14745/ccdr.v43i05a02Cox AD, Barreto L, Ulanova M, et al. Developing a vaccine for Haemophilus influenzae serotype a: Proceedings of a workshop. Can Commun Dis Rep. 2017;43(5):89–95. doi: https://doi.org/10.14745/ccdr.v43i05a02Wiese AD, Griffin MR, Grijalva CG Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States. Expert Rev Vaccines. 2019;18(4):327–341. doi: https://doi.org/10.1080/14760584.2019.1582337Wiese AD, Griffin MR, Grijalva CG Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States. Expert Rev Vaccines. 2019;18(4):327–341. doi: https://doi.org/10.1080/14760584.2019.1582337Lucero MG, Dulalia VE, Nillos LT, et al. Pneumococcal conjugate vaccines for preventing vaccine‐type invasive pneumococcal disease and X‐ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev. 2009;2009(4):CD004977. doi: https://doi.org/10.1002/14651858.CD004977.pub2Lucero MG, Dulalia VE, Nillos LT, et al. Pneumococcal conjugate vaccines for preventing vaccine‐type invasive pneumococcal disease and X‐ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev. 2009;2009(4):CD004977. doi: https://doi.org/10.1002/14651858.CD004977.pub2Sings HL, De Wals P, Gessner BD, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against invasive disease caused by serotype 3 in children: a systematic review and metaanalysis of observational studies. Clin Infect Dis. 2019;68(12):2135– 2143. doi: https://doi.org/10.1093/cid/ciy920Sings HL, De Wals P, Gessner BD, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against invasive disease caused by serotype 3 in children: a systematic review and metaanalysis of observational studies. Clin Infect Dis. 2019;68(12):2135– 2143. doi: https://doi.org/10.1093/cid/ciy920Thompson A, Gurtman A, Patterson S, et al. Safety of 13-valent pneumococcal conjugate vaccine in infants and children: meta-analysis of 13 clinical trials in 9 countries. Vaccine. 2013;31(45):5289–5295. doi: https://doi.org/10.1016/j.vaccine.2013.08.025Thompson A, Gurtman A, Patterson S, et al. Safety of 13-valent pneumococcal conjugate vaccine in infants and children: meta-analysis of 13 clinical trials in 9 countries. Vaccine. 2013;31(45):5289–5295. doi: https://doi.org/10.1016/j.vaccine.2013.08.025Ewald H, Briel M, Vuichard D, et al. The clinical effectiveness of pneumococcal conjugate vaccines: a systematic review and meta-analysis of randomized controlled trials. Dtsch Arztebl Int. 2016;113(9):139–146. doi: https://doi.org/10.3238/arztebl.2016.0139Ewald H, Briel M, Vuichard D, et al. The clinical effectiveness of pneumococcal conjugate vaccines: a systematic review and meta-analysis of randomized controlled trials. Dtsch Arztebl Int. 2016;113(9):139–146. doi: https://doi.org/10.3238/arztebl.2016.0139Jones LL, Hashim A, McKeever T, et al. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis. Respir Res. 2011;12(1):5. doi: https://doi.org/10.1186/1465-9921-12-5Jones LL, Hashim A, McKeever T, et al. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis. Respir Res. 2011;12(1):5. doi: https://doi.org/10.1186/1465-9921-12-5Watererl G, Bennett L. Improving Outcomes From Communityacquired Pneumonia. Curr Opin Pulm Med. 2015;21(3):219–225. doi: https://doi.org/10.1097/MCP.0000000000000155Watererl G, Bennett L. Improving Outcomes From Communityacquired Pneumonia. Curr Opin Pulm Med. 2015;21(3):219–225. doi: https://doi.org/10.1097/MCP.0000000000000155Gattarello S, Borgatta B, Sole-Violan J, et al. Investigators CIs. Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000– 2013). Chest. 2014;146(1):22–31. doi: https://doi.org/10.1378/chest.13-1531Gattarello S, Borgatta B, Sole-Violan J, et al. Investigators CIs. Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000– 2013). Chest. 2014;146(1):22–31. doi: https://doi.org/10.1378/chest.13-1531Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med. 2004;164(6):637– 644. doi: https://doi.org/10.1001/archinte.164.6.637Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med. 2004;164(6):637– 644. doi: https://doi.org/10.1001/archinte.164.6.637

The authors declare that there are no conflicts of interest present.